Kevin Schuyler

Filings by Kevin Schuyler span 3 companies, the busiest being Adial Pharmaceuticals, Inc., Forza X1, Inc. and Twin Vee PowerCats, Co. Over a trading history stretching from 31 July 2018 to 7 April 2026, the count stands at 18 filings.

On the market, this insider has only ever bought: 9 purchases, €48k in total. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. Since January 2026: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €4,897. Clusters matter here: 4 out of 7 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 9 April 2026, reports a share grant in Adial Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 219 days ago, on 19 March 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.